Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer
The Pharmacogenomics Journal, Published online: 27 May 2019; doi:10.1038/s41397-019-0089-xCost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - May 26, 2019 Category: Drugs & Pharmacology Authors: Malek B. Hannouf Gregory S. Zaric Phillip Blanchette Christine Brezden-Masley Mike Paulden Christopher McCabe Jacques Raphael Muriel Brackstone Source Type: research
Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s disease
Genetic association between <i>CD96</i> locus and immunogenicity to anti-TNF therapy in Crohn’s disease, Published online: 02 May 2019; doi:10.1038/s41397-019-0090-4Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s disease (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - May 1, 2019 Category: Drugs & Pharmacology Authors: Adri à Aterido N úria Palau Eugeni Dom ènech Pilar Nos Mateu Ana Guti érrez Fernando Gomoll ón Juan L. Mendoza Esther Garcia-Planella Manuel Barreiro-de Acosta Fernando Mu ñoz Maribel Vera Cristina Saro Maria Esteve Montserrat Andreu Mar ía Chaparr Source Type: research
Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid
Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid, Published online: 17 April 2019; doi:10.1038/s41397-019-0086-0Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 16, 2019 Category: Drugs & Pharmacology Authors: Laneshia K. Tague Derek E. Byers Ramsey Hachem Daniel Kreisel Alexander S. Krupnick Hrishikesh S. Kulkarni Catherine Chen Howard J. Huang Andrew Gelman Source Type: research
A genome-wide association study of tramadol metabolism from post-mortem samples
A genome-wide association study of tramadol metabolism from post-mortem samples, Published online: 11 April 2019; doi:10.1038/s41397-019-0088-yA genome-wide association study of tramadol metabolism from post-mortem samples (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 10, 2019 Category: Drugs & Pharmacology Authors: Frank R. Wendt Anna-Liina Rahikainen Jonathan L. King Antti Sajantila Bruce Budowle Source Type: research
Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis
Identification of <i>SAMD9L</i> as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis, Published online: 11 April 2019; doi:10.1038/s41397-019-0085-1Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 10, 2019 Category: Drugs & Pharmacology Authors: Jae-Jung Kim Sin Weon Yun Jeong Jin Yu Kyung Lim Yoon Kyung-Yil Lee Hong-Ryang Kil Gi Beom Kim Myung-Ki Han Min Seob Song Hyoung Doo Lee Kee Soo Ha Sejung Sohn Ryota Ebata Hiromichi Hamada Hiroyuki Suzuki Kaoru Ito Yoshihiro Onouchi Young Mi Hong Gi Young Source Type: research
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer
Prognostic impact of genetic variants of <i>CYP19A1</i> and <i>UGT2B17</i> in a randomized trial for endocrine-responsive postmenopausal breast cancer, Published online: 10 April 2019; doi:10.1038/s41397-019-0087-zPrognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 9, 2019 Category: Drugs & Pharmacology Authors: Harriet Johansson Valentina Aristarco Sara Gandini Jennifer Gjerde Debora Macis Aliana Guerrieri-Gonzaga Davide Serrano Matteo Lazzeroni Agnita Rajasekaran Clark V Williard Gunnar Mellgren Andrea DeCensi Bernardo Bonanni Source Type: research
Correction: Polymorphisms at phase I-metabolizing enzyme and
hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis
patients
Correction: Polymorphisms at phase I-metabolizing enzyme and
hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis
patientsCorrection: Polymorphisms at phase I-metabolizing enzyme and
hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis
patients, Published online: 14 February 2019; doi:10.1038/s41397-019-0084-2Correction: Polymorphisms at phase I-metabolizing enzyme and
hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis
patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 14, 2019 Category: Drugs & Pharmacology Authors: Luz M. Canet Jose M. S ánchez-Maldonado Rafael C áliz Ana Rodr íguez-Ramos Carmen B. Lupia ñez Helena Canh ão Manuel Mart ínez-Bueno Alejandro Escudero Juana Segura-Catena Signe B. Sorensen Merete L. Hetland Mar ía José Soto-Pino Miguel A. Ferrer Source Type: research
Candidate gene analyses for acute pain and morphine analgesia after pediatric day surgery: African American versus European Caucasian ancestry and dose prediction limits
Candidate gene analyses for acute pain and morphine analgesia after pediatric day surgery: African American versus European Caucasian ancestry and dose prediction limits, Published online: 14 February 2019; doi:10.1038/s41397-019-0074-4Candidate gene analyses for acute pain and morphine analgesia after pediatric day surgery: African American versus European Caucasian ancestry and dose prediction limits (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 14, 2019 Category: Drugs & Pharmacology Authors: Jin Li Zhi Wei Jie Zhang Hakon Hakonarson Scott D. Cook-Sather Source Type: research
Precision dosing of warfarin: open questions and strategies
Precision dosing of warfarin: open questions and strategies, Published online: 12 February 2019; doi:10.1038/s41397-019-0083-3Precision dosing of warfarin: open questions and strategies (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 11, 2019 Category: Drugs & Pharmacology Authors: Xi Li Dan Li Ji-Chu Wu Zhao-Qian Liu Hong-Hao Zhou Ji-Ye Yin Source Type: research
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients
<i>DPYD</i>*6 plays an important role in fluoropyrimidine toxicity in addition to <i>DPYD</i>*2A and c.2846A>T: a comprehensive analysis in 1254 patients, Published online: 06 February 2019; doi:10.1038/s41397-019-0077-1DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 6, 2019 Category: Drugs & Pharmacology Authors: Marzia Del Re Saverio Cinieri Angela Michelucci Stefano Salvadori Fotios Loupakis Marta Schirripa Chiara Cremolini Stefania Crucitta Cecilia Barbara Angelo Di Leo Tiziana Pia Latiano Filippo Pietrantonio Samantha Di Donato Paolo Simi Alessandro Passardi F Source Type: research
Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia
Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia, Published online: 06 February 2019; doi:10.1038/s41397-019-0081-5Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 6, 2019 Category: Drugs & Pharmacology Authors: Idoia Martin-Guerrero Angela Gutierrez-Camino Aizpea Echebarria-Barona Itziar Astigarraga Nagore Garcia de Andoin Aurora Navajas Africa Garcia-Orad Source Type: research
Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose
Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose, Published online: 06 February 2019; doi:10.1038/s41397-019-0080-6Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 6, 2019 Category: Drugs & Pharmacology Authors: Aurelia Viglione Flavia Chiarotti Silvia Poggini Alessandro Giuliani Igor Branchi Source Type: research
Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation
Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation, Published online: 06 February 2019; doi:10.1038/s41397-019-0082-4Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 6, 2019 Category: Drugs & Pharmacology Authors: Santiago Cuevas Van Anthony M. Villar Pedro A. Jose Source Type: research
Patient-provider communications about pharmacogenomic results increase patient recall of medication changes
Patient-provider communications about pharmacogenomic results increase patient recall of medication changes, Published online: 11 February 2019; doi:10.1038/s41397-019-0076-2Patient-provider communications about pharmacogenomic results increase patient recall of medication changes (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 4, 2019 Category: Drugs & Pharmacology Authors: Brittany A. Borden Sang Mee Lee Keith Danahey Paige Galecki Linda Patrick-Miller Mark Siegler Matthew J. Sorrentino Yasmin Sacro Andrew M. Davis David T. Rubin Kristen Lipstreuer Tamar S. Polonsky Rita Nanda William R. Harper Jay L. Koyner Deborah L. Burn Source Type: research
Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors
Genetic polymorphisms in <i>ABCG2</i> and <i>CYP1A2</i> are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors, Published online: 04 February 2019; doi:10.1038/s41397-019-0079-zGenetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 4, 2019 Category: Drugs & Pharmacology Authors: Michiel C. Verboom Jacqueline S. L. Kloth Jesse J. Swen Stefan Sleijfer Anna K. L. Reyners Neeltje Steeghs Ron H. J. Mathijssen Hans Gelderblom Henk-Jan Guchelaar Source Type: research
